14 research outputs found
Recommended from our members
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. PKM2 interaction with phosphotyrosine-containing proteins inhibits enzyme activity and increases availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small molecule PKM2 activators inhibit growth of xenograft tumors. Structural studies reveal that small molecule activators bind PKM2 at the subunit interaction interface, a site distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small molecule activation of PKM2 can interfere with anabolic metabolism
Palau’amine and Related Oroidin Alkaloids Dibromophakellin and Dibromophakellstatin Inhibit the Human 20S Proteasome
We report herein that the oroidin-derived alkaloids palau’amine
(<b>1</b>), dibromophakellin (<b>2</b>), and dibromophakellstatin
(<b>3</b>) inhibit the proteolytic activity of the human 20S
proteasome as well as the <sup><i>i</i></sup>20S immunoproteasome
catalytic core. Palau’amine is found to prevent the degradation
of ubiquitinylated proteins, including IκBα, in cell culture,
which may be indicative of the potential mechanism by which these
agents exhibit their exciting cytotoxic and immunosuppressive properties